4
Changes in Ownership
Alkermes plc. Filed Acc 0001520262-26-000110
EVP R&D, Chief Medical Officer sold 9,000 shares at $48.58 ($437,220)
- EVP R&D, Chief Medical Officer acquired 5,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Hopkinson Craig C. · EVP R&D, Chief Medical Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-08-03 | Exercise or conversion : show line 1 in the form 10b5-1 | +104 | $19.34 | $2,011 | 73,493 | D |
| 2026-08-03 | Exercise or conversion : show line 2 in the form 10b5-1 | +4,896 | $24.59 | $120,393 | 78,389 | D |
| 2026-08-03 | Sale : show line 3 in the form 10b5-1 | −9,000 | $48.58 | $437,220 | 69,389 | D |
| Open-market sales · 9,000 sh · avg $48.58 · $437,220 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-08-03 | Exercise or conversion : show line 4 in the form 10b5-1 Employee Stock Option (Right to Buy) | −104 | 1,252 | D |
| 2026-08-03 | Exercise or conversion : show line 5 in the form 10b5-1 Employee Stock Option (Right to Buy) | −4,896 | 66,276 | D |
Loading xslF345X06/form4.xml…